Cargando…

Liquorice Extract and 18β-Glycyrrhetinic Acid Protect Against Experimental Pyrrolizidine Alkaloid-Induced Hepatotoxicity in Rats Through Inhibiting Cytochrome P450-Mediated Metabolic Activation

Misuse of pyrrolizidine alkaloid (PA)-containing plants or consumption of PA-contaminated foodstuffs causes numerous poisoning cases in humans yearly, while effective therapeutic strategies are still limited. PA-induced liver injury was initiated by cytochrome P450 (CYP)-mediated metabolic activatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhangting, Ma, Jiang, Yao, Sheng, He, Yisheng, Miu, Kai-Kei, Xia, Qingsu, Fu, Peter P., Ye, Yang, Lin, Ge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966664/
https://www.ncbi.nlm.nih.gov/pubmed/35370657
http://dx.doi.org/10.3389/fphar.2022.850859
_version_ 1784678688648855552
author Wang, Zhangting
Ma, Jiang
Yao, Sheng
He, Yisheng
Miu, Kai-Kei
Xia, Qingsu
Fu, Peter P.
Ye, Yang
Lin, Ge
author_facet Wang, Zhangting
Ma, Jiang
Yao, Sheng
He, Yisheng
Miu, Kai-Kei
Xia, Qingsu
Fu, Peter P.
Ye, Yang
Lin, Ge
author_sort Wang, Zhangting
collection PubMed
description Misuse of pyrrolizidine alkaloid (PA)-containing plants or consumption of PA-contaminated foodstuffs causes numerous poisoning cases in humans yearly, while effective therapeutic strategies are still limited. PA-induced liver injury was initiated by cytochrome P450 (CYP)-mediated metabolic activation and subsequent formation of adducts with cellular proteins. Liquorice, a hepato-protective herbal medicine, is commonly used concurrently with PA-containing herbs in many compound traditional Chinese medicine formulas, and no PA-poisoning cases have been reported with this combination. The present study aimed to investigate hepato-protective effects of liquorice aqueous extract (EX) and 18β-glycyrrhetinic acid (GA, the primary bioactive constituent of liquorice) against PA-induced hepatotoxicity and the underlying mechanism. Histopathological and biochemical analysis demonstrated that both single- and multiple-treatment of EX (500 mg/kg) or GA (50 mg/kg) significantly attenuated liver damage caused by retrorsine (RTS, a representative hepatotoxic PA). The formation of pyrrole-protein adducts was significantly reduced by single- (30.3% reduction in liver; 50.8% reduction in plasma) and multiple- (32.5% reduction in liver; 56.5% reduction in plasma) treatment of GA in rats. Single- and multiple-treatment of EX also decreased the formation of pyrrole-protein adducts, with 30.2 and 31.1% reduction in rat liver and 51.8 and 53.1% reduction in rat plasma, respectively. In addition, in vitro metabolism assay with rat liver microsomes demonstrated that GA reduced the formation of metabolic activation-derived pyrrole-glutathione conjugate in a dose-dependent manner with the estimated IC(50) value of 5.07 µM. Further mechanism study showed that GA inhibited activities of CYPs, especially CYP3A1, the major CYP isoform responsible for the metabolic activation of RTS in rats. Enzymatic kinetic study revealed a competitive inhibition of rat CYP3A1 by GA. In conclusion, our findings demonstrated that both EX and GA exhibited significant hepato-protective effects against RTS-induced hepatotoxicity, mainly through the competitive inhibition of CYP-mediated metabolic activation of RTS.
format Online
Article
Text
id pubmed-8966664
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89666642022-03-31 Liquorice Extract and 18β-Glycyrrhetinic Acid Protect Against Experimental Pyrrolizidine Alkaloid-Induced Hepatotoxicity in Rats Through Inhibiting Cytochrome P450-Mediated Metabolic Activation Wang, Zhangting Ma, Jiang Yao, Sheng He, Yisheng Miu, Kai-Kei Xia, Qingsu Fu, Peter P. Ye, Yang Lin, Ge Front Pharmacol Pharmacology Misuse of pyrrolizidine alkaloid (PA)-containing plants or consumption of PA-contaminated foodstuffs causes numerous poisoning cases in humans yearly, while effective therapeutic strategies are still limited. PA-induced liver injury was initiated by cytochrome P450 (CYP)-mediated metabolic activation and subsequent formation of adducts with cellular proteins. Liquorice, a hepato-protective herbal medicine, is commonly used concurrently with PA-containing herbs in many compound traditional Chinese medicine formulas, and no PA-poisoning cases have been reported with this combination. The present study aimed to investigate hepato-protective effects of liquorice aqueous extract (EX) and 18β-glycyrrhetinic acid (GA, the primary bioactive constituent of liquorice) against PA-induced hepatotoxicity and the underlying mechanism. Histopathological and biochemical analysis demonstrated that both single- and multiple-treatment of EX (500 mg/kg) or GA (50 mg/kg) significantly attenuated liver damage caused by retrorsine (RTS, a representative hepatotoxic PA). The formation of pyrrole-protein adducts was significantly reduced by single- (30.3% reduction in liver; 50.8% reduction in plasma) and multiple- (32.5% reduction in liver; 56.5% reduction in plasma) treatment of GA in rats. Single- and multiple-treatment of EX also decreased the formation of pyrrole-protein adducts, with 30.2 and 31.1% reduction in rat liver and 51.8 and 53.1% reduction in rat plasma, respectively. In addition, in vitro metabolism assay with rat liver microsomes demonstrated that GA reduced the formation of metabolic activation-derived pyrrole-glutathione conjugate in a dose-dependent manner with the estimated IC(50) value of 5.07 µM. Further mechanism study showed that GA inhibited activities of CYPs, especially CYP3A1, the major CYP isoform responsible for the metabolic activation of RTS in rats. Enzymatic kinetic study revealed a competitive inhibition of rat CYP3A1 by GA. In conclusion, our findings demonstrated that both EX and GA exhibited significant hepato-protective effects against RTS-induced hepatotoxicity, mainly through the competitive inhibition of CYP-mediated metabolic activation of RTS. Frontiers Media S.A. 2022-03-16 /pmc/articles/PMC8966664/ /pubmed/35370657 http://dx.doi.org/10.3389/fphar.2022.850859 Text en Copyright © 2022 Wang, Ma, Yao, He, Miu, Xia, Fu, Ye and Lin. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Wang, Zhangting
Ma, Jiang
Yao, Sheng
He, Yisheng
Miu, Kai-Kei
Xia, Qingsu
Fu, Peter P.
Ye, Yang
Lin, Ge
Liquorice Extract and 18β-Glycyrrhetinic Acid Protect Against Experimental Pyrrolizidine Alkaloid-Induced Hepatotoxicity in Rats Through Inhibiting Cytochrome P450-Mediated Metabolic Activation
title Liquorice Extract and 18β-Glycyrrhetinic Acid Protect Against Experimental Pyrrolizidine Alkaloid-Induced Hepatotoxicity in Rats Through Inhibiting Cytochrome P450-Mediated Metabolic Activation
title_full Liquorice Extract and 18β-Glycyrrhetinic Acid Protect Against Experimental Pyrrolizidine Alkaloid-Induced Hepatotoxicity in Rats Through Inhibiting Cytochrome P450-Mediated Metabolic Activation
title_fullStr Liquorice Extract and 18β-Glycyrrhetinic Acid Protect Against Experimental Pyrrolizidine Alkaloid-Induced Hepatotoxicity in Rats Through Inhibiting Cytochrome P450-Mediated Metabolic Activation
title_full_unstemmed Liquorice Extract and 18β-Glycyrrhetinic Acid Protect Against Experimental Pyrrolizidine Alkaloid-Induced Hepatotoxicity in Rats Through Inhibiting Cytochrome P450-Mediated Metabolic Activation
title_short Liquorice Extract and 18β-Glycyrrhetinic Acid Protect Against Experimental Pyrrolizidine Alkaloid-Induced Hepatotoxicity in Rats Through Inhibiting Cytochrome P450-Mediated Metabolic Activation
title_sort liquorice extract and 18β-glycyrrhetinic acid protect against experimental pyrrolizidine alkaloid-induced hepatotoxicity in rats through inhibiting cytochrome p450-mediated metabolic activation
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966664/
https://www.ncbi.nlm.nih.gov/pubmed/35370657
http://dx.doi.org/10.3389/fphar.2022.850859
work_keys_str_mv AT wangzhangting liquoriceextractand18bglycyrrhetinicacidprotectagainstexperimentalpyrrolizidinealkaloidinducedhepatotoxicityinratsthroughinhibitingcytochromep450mediatedmetabolicactivation
AT majiang liquoriceextractand18bglycyrrhetinicacidprotectagainstexperimentalpyrrolizidinealkaloidinducedhepatotoxicityinratsthroughinhibitingcytochromep450mediatedmetabolicactivation
AT yaosheng liquoriceextractand18bglycyrrhetinicacidprotectagainstexperimentalpyrrolizidinealkaloidinducedhepatotoxicityinratsthroughinhibitingcytochromep450mediatedmetabolicactivation
AT heyisheng liquoriceextractand18bglycyrrhetinicacidprotectagainstexperimentalpyrrolizidinealkaloidinducedhepatotoxicityinratsthroughinhibitingcytochromep450mediatedmetabolicactivation
AT miukaikei liquoriceextractand18bglycyrrhetinicacidprotectagainstexperimentalpyrrolizidinealkaloidinducedhepatotoxicityinratsthroughinhibitingcytochromep450mediatedmetabolicactivation
AT xiaqingsu liquoriceextractand18bglycyrrhetinicacidprotectagainstexperimentalpyrrolizidinealkaloidinducedhepatotoxicityinratsthroughinhibitingcytochromep450mediatedmetabolicactivation
AT fupeterp liquoriceextractand18bglycyrrhetinicacidprotectagainstexperimentalpyrrolizidinealkaloidinducedhepatotoxicityinratsthroughinhibitingcytochromep450mediatedmetabolicactivation
AT yeyang liquoriceextractand18bglycyrrhetinicacidprotectagainstexperimentalpyrrolizidinealkaloidinducedhepatotoxicityinratsthroughinhibitingcytochromep450mediatedmetabolicactivation
AT linge liquoriceextractand18bglycyrrhetinicacidprotectagainstexperimentalpyrrolizidinealkaloidinducedhepatotoxicityinratsthroughinhibitingcytochromep450mediatedmetabolicactivation